About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
HISTORICAL VOLUME
Historical
Volume
Mankind Pharma Ltd.
BSE Code
543904
ISIN Demat
INE634S01028
Book Value
334.22
NSE Code
MANKIND
Dividend Yield %
0.00
Market Cap
1156610.67
P/E
57.03
EPS
49.15
Face Value
1
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2024
2023
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2024
2023
Date
Open Price(Rs.)
High Price(Rs.)
Low Price(Rs.)
Close Price(Rs.)
Volume
Turnover
20-Dec-2024
2891.05
2905.20
2780.00
2803.45
15532
44116575
19-Dec-2024
2788.70
2920.05
2743.80
2889.45
34512
98591675
18-Dec-2024
2662.05
2851.15
2626.05
2805.55
41134
114452605
17-Dec-2024
2748.65
2753.00
2649.75
2661.20
24368
65904649
16-Dec-2024
2648.00
2696.00
2626.85
2690.80
4241
11291765
13-Dec-2024
2636.35
2718.60
2610.65
2640.30
19755
52524595
12-Dec-2024
2630.00
2672.70
2630.00
2650.55
10482
27758474
11-Dec-2024
2630.35
2689.55
2617.65
2623.10
9084
23991735
10-Dec-2024
2660.55
2684.95
2609.85
2668.75
12777
33907870
09-Dec-2024
2590.05
2650.00
2570.00
2640.05
10088
26439176
06-Dec-2024
2600.30
2620.80
2571.75
2585.10
8668
22501151
05-Dec-2024
2601.95
2638.75
2569.45
2619.10
14688
38272197
04-Dec-2024
2589.95
2617.75
2553.40
2597.25
8713
22578641
03-Dec-2024
2626.35
2637.50
2552.05
2558.95
5738
14785432
02-Dec-2024
2532.05
2623.45
2532.05
2615.30
19495
50610800
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.